DOCSLIB.ORG

Ibec Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ibec Annual Report IBEC ANNUAL REPORT 09 IBEC ANNUAL REPORT 09 “This Annual Report is the evidence of the work and effort to consolidate the position of IBEC as an international centre of reference” INTRODUCTION LETTER IBEC ANNUAL REPORT 09 3 It is with great satisfaction that I am presenting our 2009 Annual Report, a concise review of the work of the Institute over the last twelve months that bears witness to the consistent effort and solid achievements of all those who are working to further improve and develop this institution. This systematic review of our activities will, in time, serve as a record of the history of the IBEC, but we also want it to be a communicative tool that will inform those who read it about our scientific competence, our technological expertise, the talent we foster, and the excellent return we provide for the investment that finances our organisation. In terms of the research output in the last year, we have seen no increase in the number of scientific articles published, but there has been a marked increase in terms of impact of our publications, a good sign aligned with the objective to improve the quality/quantity balance. At the same time, we continue to attract talent from both our close surroundings and from abroad. In terms of competitive funding, the number of projects applied for and the funds received have both increased significantly, another good sign with respect to the quality/quantity balance we are looking for, since the responsibility for coordinating both National and European projects has also increased. In 2010, we will have the opportunity to increase and improve both the applicability and the transfer of our research. The consolidation of our Molecular and Cellular Neurobiotechnology research line and the incorporation of a new line of research, Control of Stem Cell Potency, represent significant progress in terms of IBEC’s interdisciplinary scientific ambitions. This expansion in the number of research groups has produced an increase in the number of researchers and the need for more space. In 2009, we have managed to bring all the teams together and to provide each research group with its own space. We can congratulate ourselves that all the research groups have now working space within the IBEC facilities. I would like to conclude by saying that our ambition to consolidate the position of IBEC as an international centre of reference in bioengineering and nanomedicine is alive and I hope that this Annual Report is the evidence of the work and effort that all of us, as IBEC members, are investing in achieving that goal. The relocation of the research groups in good laboratories, their proximity to one another, the interdisciplinary nature of our research teams, and the quality of our administration and support services will allow us to keep improving and making further progress not only towards the achievement of our own objectives but also towards the fulfillment of our social function of contributing to a better quality of life for everyone through advances in bioengineering and nanomedical research. Thank you! Josep A. Planell IBEC ANNUAL REPORT 09 5 HIGHLIGHTS 07 ORGANISATION 11 THE IBEC PRIVATE FOUNDATION 12 ORGANISATIONAL CHART 13 ORGANISATIONAL STRUCTURE 14 RESEARCH 17 RESEARCH LINES 18 RESEARCH PROJECTS 33 PUBLICATIONS 38 COLLABORATIONS WITH OTHER 42 RESEARCH CENTRES SCIENTIFIC EQUIPMENT AND 46 TECHNIQUES IBEC INITIATIVES 49 INSTITUTIONAL PROJECTS 50 AND ACTIVITIES STRATEGIC ALLIANCES 52 SEMINARS AND LECTURES 54 CONFERENCES AND SYMPOSIA 56 CONTENTS IBEC ANNUAL REPORT 09 7 HIGHLIGHTS HIGHLIGHTS IBEC Expands its Research Collaboration Agreements Program with a New Line of In the context of the Biopol’H project, IBEC and the Bellvitge Institute for Biomedical Research (IDIBELL) have signed a collabo- Stem Cell Investigation ration agreement covering the exchange of human resources, the organization of joint activities, shared use of facilities and equipment, Control of Stem Cell Potency is a research line recently initiated and participation in joint projects. The two institutes will collabora- under the leadership of Ángel Raya, a research professor at the te in the following areas: transplantation; bioengineering; implants; Catalan Institute for Research and Advanced Studies (ICREA). This tissue engineering and biocompatibility; new medical imaging tech- is within IBEC’s Cellular Biotechnology research programme. nologies; new technologies for molecular and genetic diagnosis; The focus of this new line of research is the regeneration of complex biomedical and bioelectronic engineering; and the neurosciences. structures, the biotechnology of cell reprogramming, and stem cell IBEC has signed a memorandum of understanding (MOU) with differentiation. The team uses the paradigm of heart (re)genera- the National Institute for Materials Science (NIMS) in Japan on the tion to address the basic question of how a discrete and defined “Design of Biomaterial Surfaces and Biosensors for Cell Function degree of developmental potency can be imposed on somatic cells, Manipulation and Analysis”. Under this agreement, NIMS and enabling them to regain the capacity to regenerate a functional IBEC will promote the exchange of researchers and information, structure or tissue. With this addition, the IBEC foundation now cooperate in research and development projects, and publish the has 15 research lines and is further consolidating the growth of its results of such research jointly. programmes of investigation. IBEC also signed a research agreement with the Interstaatliche Hochschule für Technick Buchs in Switzerland for cooperation 2nd IBEC Symposium on the “Development and fabrication of advanced polymeric 3D microfluidic structures”. The two research centres will contribute on Bioengineering and their knowledge and expertise to this project and collaborate on the Nanomedicine Held implementation of the results of the research in future applications. in Barcelona 2nd Annual Conference of the Some 300 scientists gathered at the World Trade Center in Barce- lona on 14th and 15th April for the 2nd IBEC Annual Symposium. Spanish Technology Platforms The participants presented details of their most recent research in on Biomedical Research, the areas of bioengineering and nanomedicine. Keynote speakers from Europe and the United States were internationally renowned Innovative Medicine, and scientists including Dr. Martin Bennink of the University of Twente in the Netherlands, Professor Alan Gelperin of the Monell Chemical Nanomedicine Senses Center in Philadelphia, Professor Frederick Grinnell of the The second annual conference of the Spanish Technology Pla- Southwestern Medical Center at the University of Texas, Profes- tform on Nanomedicine (Nanomed Spain) and the Spanish Tech- sor Michael Sheetz of Columbia University, Professor Keita Ito of nological Platform for Innovative Medicines took place in Madrid Eindhoven University in the Netherlands, Professor Nongjian Tao of on 27 and 28 January. This event is a meeting place for com- Arizona State University, and Angel Raya of the Center of Regene- panies and institutions working in these areas. The two Spanish rative Medicine in Barcelona. technology platforms working in the field of biomedicine presented their current projects. In particular, Nanomed Spain chose this conference to officially present its international innovation unit, Nanomed-UII. Another item of particular interest was the presen- tation describing the development of the roadmap for nanomedici- ne drawn up by the European Technology Platform on Nanomedi- cine, of which both IBEC and Nanomed Spain are members. Opening of NANOMED-UII, IBEC Hosts the 2nd China- the International Innovation Europe Symposium on Unit of the Spanish Platform Biomaterials in Regenerative on Nanomedicine Medicine Nanomed-UII was created in January 2009 as a result of a con- The 2nd China-Europe Symposium on Biomaterials in Regenerati- tract between the Spanish Platform on Nanomedicine (Nanomed ve Medicine took place in Barcelona from 16 to 20 November. This Spain) and the Centre for the Development of Industrial Tech- event brought together over 150 participants and the top spe- nology (CDTI). The mission of this international innovation unit cialists in biomaterials from China and Europe. The symposium, is to improve the participation of Spanish companies in projects organised by IBEC, was a joint initiative of the European Society financed by the European Union’s seventh framework programme, for Biomaterials and the Chinese Committee for Biomaterials. The in particular with respect to the application of nanotechnology goal was to showcase the latest research, to provide a forum for to healthcare. Nanomed-UII is now integrated into the existing the discussion of recent advances, to build relationships between structure of Nanomed Spain, a body established in 2005 which is European and Chinese researchers, and to promote collaboration coordinated by IBEC. in future research projects. The aim of this technology platform, which affiliates over 100 companies, hospitals and publically-funded research centres, in IBEC at Japan´s Nano Tech addition to representatives of official bodies, is to bring together the public and private sectors and develop joint strategies aimed at 2009 advancing the field of nanomedicine in Spain. IBEC attended the International Nanotechnology Exhibition and Conference, one of the world’s largest nanotechnology exhibitions, UK-Iberia Nanomedicine which took place in Tokyo from 18 to 20 February,
Load more

Recommended publications
  • Biopolymeric Materials for Tissue Regeneration, Cell Manufacturing, and Drug Delivery
    University of Arkansas, Fayetteville ScholarWorks@UARK Theses and Dissertations 5-2021 Biopolymeric Materials for Tissue Regeneration, Cell Manufacturing, and Drug Delivery David Alfonso Castilla-Casadiego University of Arkansas, Fayetteville Follow this and additional works at: https://scholarworks.uark.edu/etd Part of the Polymer and Organic Materials Commons, and the Polymer Science Commons Citation Castilla-Casadiego, D. A. (2021). Biopolymeric Materials for Tissue Regeneration, Cell Manufacturing, and Drug Delivery. Theses and Dissertations Retrieved from https://scholarworks.uark.edu/etd/3964 This Dissertation is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of ScholarWorks@UARK. For more information, please contact [email protected]. Biopolymeric Materials for Tissue Regeneration, Cell Manufacturing, and Drug Delivery A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Engineering with a concentration in Chemical Engineering by David Alfonso Castilla-Casadiego Atlantic University Bachelor of Science in Chemical Engineering, 2011 University of Puerto Rico – Mayagüez Campus Master of Science in Chemical Engineering, 2016 May 2021 University of Arkansas This dissertation is approved for recommendation to the Graduate Council. ____________________________________ Jorge L. Almodóvar-Montañez, Ph.D. Dissertation Director ____________________________________ _________________________________
    [Show full text]
  • Boosting the Cellular Potency of Embryonic Stem Cells by Spliceosome Targeting ✉ Wilfried A
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans RESEARCH HIGHLIGHT OPEN Boosting the cellular potency of embryonic stem cells by spliceosome targeting ✉ Wilfried A. Kues1 Signal Transduction and Targeted Therapy (2021) 6:324; https://doi.org/10.1038/s41392-021-00743-9 In recent work published in Cell, Shen et al.1 identified transfected ES cells with short interfering RNAs against different spliceosome inhibition in embryonic stem (ES) cells as a key spliceosome transcripts (the spliceosome consisted of 5 core and mechanism for the transition from pluri- to totipotency. Spliceo- several cofactor subunits, here 14 transcripts were targeted), some inhibition, achieved by RNA interference or the chemical respectively. Transient repression of 10 of the 14 splicing factors inhibitor pladienolide B, may gain widespread relevance to the resulted in ES cells, which maintained the typical colony culture of totipotent ES cells, in vitro differentiation of extra- morphology, however, pluripotent marker genes—Oct4 (Pou5f1), embryonal tissue and organoids, translation to the maintenance of Nanog, Sox2, Zfp42 and others—became down-regulated, at the pluripotent cells of other mammal species, including humans, and same time marker genes of totipotency—particularly Zscan4s and a better molecular understanding of cellular potency in stem cells MERVL—were up-regulated. Zscan4s (Zink finger and SCAN and cancer. domain containing 4) is a transcription factor and MERVL (murine The first successful isolation and maintenance of ES derived endogenous retrovirus L) an endogenous retrovirus with a usually fi 1234567890();,: from the inner cell mass (ICM) of murine blastocyst stages was restricted expression to 2-cell embryos. These results were veri ed described in 1981,2 and since then acted as game changer for by supplementing the culture medium with pladienolide B, a genetic studies in this mammalian model organism.
    [Show full text]
  • Engineering Lineage Potency and Plasticity of Stem Cells Using Epigenetic Molecules Received: 13 December 2017 Anandika Dhaliwal1, Sandra Pelka1, David S
    www.nature.com/scientificreports OPEN Engineering Lineage Potency and Plasticity of Stem Cells using Epigenetic Molecules Received: 13 December 2017 Anandika Dhaliwal1, Sandra Pelka1, David S. Gray1 & Prabhas V. Moghe 1,2 Accepted: 11 October 2018 Stem cells are considered as a multipotent regenerative source for diseased and dysfunctional Published: xx xx xxxx tissues. Despite the promise of stem cells, the inherent capacity of stem cells to convert to tissue- specifc lineages can present a major challenge to the use of stem cells for regenerative medicine. We hypothesized that epigenetic regulating molecules can modulate the stem cell’s developmental program, and thus potentially overcome the limited lineage diferentiation that human stem cells exhibit based on the source and processing of stem cells. In this study, we screened a library of 84 small molecule pharmacological agents indicated in nucleosomal modifcation and identifed a sub-set of specifc molecules that infuenced osteogenesis in human mesenchymal stem cells (hMSCs) while maintaining cell viability in-vitro. Pre-treatment with fve candidate hits, Gemcitabine, Decitabine, I-CBP112, Chidamide, and SIRT1/2 inhibitor IV, maximally enhanced osteogenesis in-vitro. In contrast, fve distinct molecules, 4-Iodo-SAHA, Scriptaid, AGK2, CI-amidine and Delphidine Chloride maximally inhibited osteogenesis. We then tested the role of these molecules on hMSCs derived from aged human donors and report that small epigenetic molecules, namely Gemcitabine and Chidamide, can signifcantly promote osteogenic diferentiation by 5.9- and 2.3-fold, respectively. Taken together, this study demonstrates new applications of identifed small molecule drugs for sensitively regulating the lineage plasticity fates of bone-marrow derived mesenchymal stem cells through modulating the epigenetic profle of the cells.
    [Show full text]
  • Stem Cell Therapy and Gene Transfer for Regeneration
    Gene Therapy (2000) 7, 451–457 2000 Macmillan Publishers Ltd All rights reserved 0969-7128/00 $15.00 www.nature.com/gt MILLENNIUM REVIEW Stem cell therapy and gene transfer for regeneration T Asahara, C Kalka and JM Isner Cardiovascular Research and Medicine, St Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA, USA The committed stem and progenitor cells have been recently In this review, we discuss the promising gene therapy appli- isolated from various adult tissues, including hematopoietic cation of adult stem and progenitor cells in terms of mod- stem cell, neural stem cell, mesenchymal stem cell and ifying stem cell potency, altering organ property, accelerating endothelial progenitor cell. These adult stem cells have sev- regeneration and forming expressional organization. Gene eral advantages as compared with embryonic stem cells as Therapy (2000) 7, 451–457. their practical therapeutic application for tissue regeneration. Keywords: stem cell; gene therapy; regeneration; progenitor cell; differentiation Introduction poietic stem cells to blood cells. The determined stem cells differentiate into ‘committed progenitor cells’, which The availability of embryonic stem (ES) cell lines in mam- retain a limited capacity to replicate and phenotypic fate. malian species has greatly advanced the field of biologi- In the past decade, researchers have defined such com- cal research by enhancing our ability to manipulate the mitted stem or progenitor cells from various tissues, genome and by providing model systems to examine including bone marrow, peripheral blood, brain, liver cellular differentiation. ES cells, which are derived from and reproductive organs, in both adult animals and the inner mass of blastocysts or primordial germ cells, humans (Figure 1).
    [Show full text]
  • Measurement of Hematopoietic Stem Cell Potency Prior to Transplantation
    WHITE PAPER Measurement of Hematopoietic Stem Cell Potency Prior to Transplantation February, 2009 This White Paper is a forward-looking statement. It represents the present state of the art and future technology in the field of stem cell potency testing. The views expressed in this White Paper are those of HemoGenix®, Inc. Changing the Paradigm Introduction The increased number of potential cellular therapies over recent years has necessitated stricter regulations to improve efficacy of the treatment and reduce risk to the patient. One of the regulations that was implemented by the European Medicines Agency (EMEA), Committee for Medicinal Products for Human Use (CHMP) on 15 May 2008 and the publication of a Draft Guidance by the United States Food and Drug Administration (FDA) in October 2008, was the requirement to measure the potency of a cellular product prior to administration to the patient. There have been two primary difficulties with these regulations. One of the difficulties encountered by the cellular therapy field is the understanding of what potency of a cellular product means. In the United States (U.S.), potency is actually defined in the Code of Federal Regulations (CFR) in Section 21, 600.3 “to mean the specific ability or capacity of the product, as indicated by appropriate laboratory tests or by adequately controlled clinical data obtained through the administration of the product in the manner intended, to effect a given result”. In the implemented EMEA “Guideline on potency testing of cell based immunotherapy medicinal products for the treatment of cancer”, potency is simply indicated as a “quantitative measure of biological activity” of the cell based immunotherapy product.
    [Show full text]
  • Stem Cell Potency
    Stem Cell Potency By Rebecca Chan “Time is a circus, always packing up and moving away.” —Ben Hecht In a way, we never gave up trying to find that elixir of immortality. We try to better our lives or the way we live our lives because we have limited TIME. Stem cells are looked at as possible treatment to many diseases. These cells are bewildering because they share two properties: 1. Self-Renewal: the ability to undergo cell division and remain undifferentiated 2. Potency: the ability to differentiate to specialized cell types Toipotentcy A single totipotent cell is limitless and can divide and produce all differentiated cells of an organism into identical totipotent cells. Example: zygote, a fertilized egg cell. Humans emerge from that single totipotent cell. What was it like to have the ability to do anything? Were we ever given that chance? In kindergarten, we were asked what we wanted to be when we grew up. We were given anything to choose from, and there wasn’t any right or wrong answer. Scientist, astronaut, doctor, teacher, veterinarian, firefighter, and racecar driver were some of the answers given. When it came to me, I called out, “Everything.” I wanted to be everything. The teacher laughed and said, “Choose one.” I repeated, “Everything.” Why couldn’t I be everything? Barbie was everything and could do everything. Why not everything? The teacher gave me an odd look before she moved on. But the next guy’s answer wasn’t that far off from mine. “I want to be a superhero! A superhero, like Batman.” Pluripotency Pluripotency is the next level down from totipotency.
    [Show full text]
  • Biological Sciences
    A Comprehensive Book on Environmentalism Table of Contents Chapter 1 - Introduction to Environmentalism Chapter 2 - Environmental Movement Chapter 3 - Conservation Movement Chapter 4 - Green Politics Chapter 5 - Environmental Movement in the United States Chapter 6 - Environmental Movement in New Zealand & Australia Chapter 7 - Free-Market Environmentalism Chapter 8 - Evangelical Environmentalism Chapter 9 -WT Timeline of History of Environmentalism _____________________ WORLD TECHNOLOGIES _____________________ A Comprehensive Book on Enzymes Table of Contents Chapter 1 - Introduction to Enzyme Chapter 2 - Cofactors Chapter 3 - Enzyme Kinetics Chapter 4 - Enzyme Inhibitor Chapter 5 - Enzymes Assay and Substrate WT _____________________ WORLD TECHNOLOGIES _____________________ A Comprehensive Introduction to Bioenergy Table of Contents Chapter 1 - Bioenergy Chapter 2 - Biomass Chapter 3 - Bioconversion of Biomass to Mixed Alcohol Fuels Chapter 4 - Thermal Depolymerization Chapter 5 - Wood Fuel Chapter 6 - Biomass Heating System Chapter 7 - Vegetable Oil Fuel Chapter 8 - Methanol Fuel Chapter 9 - Cellulosic Ethanol Chapter 10 - Butanol Fuel Chapter 11 - Algae Fuel Chapter 12 - Waste-to-energy and Renewable Fuels Chapter 13 WT- Food vs. Fuel _____________________ WORLD TECHNOLOGIES _____________________ A Comprehensive Introduction to Botany Table of Contents Chapter 1 - Botany Chapter 2 - History of Botany Chapter 3 - Paleobotany Chapter 4 - Flora Chapter 5 - Adventitiousness and Ampelography Chapter 6 - Chimera (Plant) and Evergreen Chapter
    [Show full text]
  • 2018 BMES MOBILE THURSDAY Annual Meeting Platform Sessions Th-1 APP (Thursday 8:00-9:30Am)
    TABLE OF CONTENTS TABLE SCIENTIFIC PROGRAM 2018 BMES MOBILE THURSDAY Annual Meeting Platform Sessions Th-1 APP (Thursday 8:00-9:30am) ....................................... 4–13 Go to the Apple or Android Store and search for: Platform Sessions Th-2 BMES (Thursday 1:30-3:00pm) ....................................14–22 Download the Free App > Select BMES2018 Platform Sessions Th-3 (Thursday 3:45-5:15pm) ....................................23–31 Poster Sessions–Thursday ..............................32–91 Browse the program by date or session type FRIDAY Platform Sessions Fri-1 keywords Search (Friday 8:00-9:30am) ....................................... 93–101 Search Author list Platform Sessions Fri-2 Add presentations to (Friday 1:15-2:45pm) .................................. 102–110 a custom itinerary Platform Sessions Fri-3 Click a link to show (Friday 3:30-5:00pm) .................................... where a presentation 111–119 is on the map of the convention center Poster Sessions–Friday .............................. 120–179 SATURDAY Platform Sessions Sat-1 (Saturday 8:00am-9:30am) .........................180–189 Platform Sessions Sat-2 Don't forget to turn your BMES (Saturday 1:30-3:00pm) ............................... 190–198 BASH ticket in for a wristband at Platform Sessions Sat-3 (Saturday 3:15-4:45pm) ...............................199–205 the information or registration Poster Sessions–Saturday ....................... 206–249 booths before Friday afternoon Omni Hotel Floorplan ..........................................
    [Show full text]
  • The Science and Ethics of Stem Cell Research
    Plenty of Planaria The Science Teacher Overview and Ethics of Stem Cell Research Objectives Purpose Students will be able to: The purpose of this lesson is to introduce students to fundamental • Distinguish between types of stem cell concepts using brown planaria (Dugesia tigrina) as stem cell potency (totipotent, a model organism. This model works well for demonstrating pluripotent, and multipotent). stem cell function, development, and the complexity of tissue • Compare planaria stem cells to regeneration. This lesson also functions as a starting point for human stem cells. students to begin thinking about the concept of regeneration and stem cells in other organisms. • Design unique questions to test planaria regeneration, and Key Concepts analyze their data in support of • Stem cells are undifferentiated cells that can make more of a conclusion. themselves (self-renew) and can develop into specific cell types • Synthesize and evaluate trends (differentiate). in class data. • TOTIPOTENT stem cells are capable of regenerating ALL cells Class Time present in the organism, in contrast to PLURIPOTENT stem • 1 class period for initial cells (which can make most cells) and MULTIPOTENT stem laboratory. cells (which can make cells within a tissue type). • 10-15 minutes each day over the • Totipotent cells begin as non-differentiated cells and then course of the next week or two commit to a developmental pathway to become differentiated. to record observations. Alternatively, they can divide to make more totipotent cells. • 1 class period for data results • Planaria are capable of regeneration of a wide range of and analysis. tissue structures due to the presence of totipotent cells – the ‘neoblasts’ – which divide by mitosis.
    [Show full text]
  • Computational Stem Cell Biology: Open Questions and Guiding Principles
    ll Perspective Computational Stem Cell Biology: Open Questions and Guiding Principles Patrick Cahan,1,13,14,* Davide Cacchiarelli,2,13 Sara-Jane Dunn,3,4,13 Martin Hemberg,5,13 Susana M. Chuva de Sousa Lopes,6,13 Samantha A. Morris,7,13 Owen J.L. Rackham,8,13 Antonio del Sol,9,10,11,13 and Christine A. Wells12,13 1Institute for Cell Engineering, Department of Biomedical Engineering, Department of Molecular Biology and Genetics, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA 2Telethon Institute of Genetics and Medicine (TIGEM), Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy d Department of Translational Medicine, University of Naples ‘‘Federico II,’’ Naples, Italy 3DeepMind, 14-18 Handyside Street, London N1C 4DN, UK 4Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge Biomedical Campus, Cambridge CB2 0AW, UK 5Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK 6Department Anatomy and Embryology, Leiden University Medical Center, Einthovenweg 20, Leiden, the Netherlands 7Department of Developmental Biology, Department of Genetics, Center of Regenerative Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA 8Centre for Computational Biology and The Program for Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, Singapore 9Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6 Avenue du Swing, Belvaux 4366, Luxembourg 10CIC bioGUNE, Bizkaia
    [Show full text]
  • Metabolic Regulation of Cell Differentiation
    Advanced Chemicobiology Research http://ojs.wiserpub.com/index.php/ACBR/ Mini Review Metabolic Regulation of Cell Differentiation Elizabeth Frayne College of General Studies, University of Phoenix, USA Email: [email protected] Received: 20 July 2020; Revised: 3 September 2020; Accepted: 19 October 2020 Abstract: Growing research suggests that metabolism itself may play a role in regulating cellular differentiation. This concept stems from three different experimental approaches involving hypoxia, nutrient metabolites, and phosphate analogues, that appear to modulate cellular differentiation by influencing the available cellular energy needed for biosynthetic processes. Possible explanatory mechanisms that could lead to the integration of changes in metabolism with transcriptional regulation include the availability of key metabolites needed for epigenetic changes to occur and/or kinases that can sense the cellular energy charge. Keywords: cell differentiation, adenylate energy charge, phosphate analogues 1. Introduction Current research raises the question of whether metabolic activity is a cause or a consequence of cell differentiation [1-2]. Clearly cell differentiation results from cell specialization and the synthesis of specific macromolecules such as proteins, all of which requires energy. Generally, there is an increase in mRNA and concomitant protein synthesis via enhanced transcription, stabilization of mRNA, and/or the translation of stored mRNAs. We know that signaling mechanisms or cues such as growth factors, retinoic acid, and cytoplasmic determinants, as well as asymmetric cell division, play a role in these processes [3]. Also, epigenetic changes are known to be involved in regulating the decision to adopt a cell fate, such as deciding between a stem cell, progenitor, or a mature cell fate [4].
    [Show full text]
  • Biomedical Applications of Induced Pluripotent Stem Cells
    Review Article Annals of Stem Cells and Regenerative Medicine Published: 31 Oct, 2019 Biomedical Applications of Induced Pluripotent Stem Cells Neveen A Salem1,2* 1Department of Biochemistry, University of Jeddah, Saudi Arabia 2Department of Narcotics, Ergogenic Aids and Poisons, Division of Medical Research, National Research Centre, Egypt Abstract Induced Pluripotent Stem Cells (iPSCs) which are efficiently produced from somatic cells by the introduction of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) in fibroblasts could circumvent the restrictions of multipotent stem cells that obligated to differentiate into only several lineage cells and also, the ethical argument about ESCs that causes oocytes and embryo destruction. In addition, iPSCs are powerful tools applicable in biomedicine, cell therapy, pharmacology and toxicology. Therefore, the use of iPSCs in stem cell therapy has immense prospects and offer remarkable applications in regenerative medicine. This review aimed to summarize the most recent findings on iPSCs and focus on their biomedical applications. Introduction Stem cells are unspecialized cells in the human body that possesses two prominent properties: a capability for self-renewal and potency, which is the efficiency of proliferation and differentiation to various cellular lineages under suitable conditions. Essentially, stem cell stays uncommitted until it is signaled to change into a specialized cell. Stem cells have the special properties of developing into an expansion of different cells in the human body. They function as a repair system by being able to divide without restriction to replenish other cells [1]. Self Renewal of Stem Cells Stem cells fate is decided by their communication with the surrounding niche or microenvironment.
    [Show full text]